283 related articles for article (PubMed ID: 11705631)
1. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
Das P; Murphy MP; Younkin LH; Younkin SG; Golde TE
Neurobiol Aging; 2001; 22(5):721-7. PubMed ID: 11705631
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.
Das P; Howard V; Loosbrock N; Dickson D; Murphy MP; Golde TE
J Neurosci; 2003 Sep; 23(24):8532-8. PubMed ID: 13679422
[TBL] [Abstract][Full Text] [Related]
3. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
4. Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.
Levites Y; Das P; Price RW; Rochette MJ; Kostura LA; McGowan EM; Murphy MP; Golde TE
J Clin Invest; 2006 Jan; 116(1):193-201. PubMed ID: 16341263
[TBL] [Abstract][Full Text] [Related]
5. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
[TBL] [Abstract][Full Text] [Related]
6. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
[TBL] [Abstract][Full Text] [Related]
7. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.
Sigurdsson EM; Scholtzova H; Mehta PD; Frangione B; Wisniewski T
Am J Pathol; 2001 Aug; 159(2):439-47. PubMed ID: 11485902
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
[TBL] [Abstract][Full Text] [Related]
10. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
[TBL] [Abstract][Full Text] [Related]
12. Knockout of apolipoprotein A-I decreases parenchymal and vascular β-amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
Contu L; Carare RO; Hawkes CA
Neuropathol Appl Neurobiol; 2019 Dec; 45(7):698-714. PubMed ID: 31002190
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.
Frost JL; Liu B; Kleinschmidt M; Schilling S; Demuth HU; Lemere CA
Neurodegener Dis; 2012; 10(1-4):265-70. PubMed ID: 22343072
[TBL] [Abstract][Full Text] [Related]
14. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
[TBL] [Abstract][Full Text] [Related]
15. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
17. HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses.
Bowers WJ; Mastrangelo MA; Stanley HA; Casey AE; Milo LJ; Federoff HJ
Neurobiol Aging; 2005 Apr; 26(4):393-407. PubMed ID: 15653168
[TBL] [Abstract][Full Text] [Related]
18. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
19. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
20. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
